BHCM
SYRS

Brevan Howard Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Brevan Howard Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,036
Closed -$85.8K – 1413
2024
Q1 		$85.8K Buy
+16,036
New +$85.8K ﹤0.01% 858